Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Bargetzi

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Therapeutische Umschau. Revue Therapeutique|March 17, 2004
[Etiology and treatment of thrombocytopenia]M J Bargetzi
Therapeutische Umschau. Revue Therapeutique|February 3, 2006
[Leukopenia/neutropenia]M J Bargetzi
Schweizerische Medizinische Wochenschrift|March 23, 1991
[Bronchopulmonary sequestration]M J Bargetzi, J Saltzman, W Maurer
Journal of Immunological Methods|June 2, 1989
Diagnostic screening of multiple antigen-antibody reactions in a new single assay on nitrocellulose: the line immunobinding assay (LIBA)R E Aeppli, M J Bargetzi, H Binz
Helvetica Chirurgica Acta|December 1, 1987
[Duodenopancreatectomy: the results with 35 patients]R A Schori, M J Bargetzi, W Maurer
Schweizerische Medizinische Wochenschrift|November 9, 1996
[Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia]M J Bargetzi, A Tichelli, A Gratwohl, et al.
Biochemical and Biophysical Research Communications|November 13, 1987
MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylationR Fonne-Pfister, M J Bargetzi, U A Meyer
JAMA|February 10, 1989
Premenstrual exacerbations in hepatic porphyria: prevention by intermittent administration of an LH-RH agonist in combination with a gestagenM J Bargetzi, U A Meyer, M H Birkhaeuser
The American Journal of Medicine|October 1, 1990
Primary liver carcinoma in two sisters with acute intermittent porphyriaJ G Gubler, M J Bargetzi, U A Meyer
American Journal of Hematology|June 26, 2001
Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLLM Heizmann, P Itin, M Wernli, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|March 17, 2004
[Etiology and treatment of thrombocytopenia]M J Bargetzi
Therapeutische Umschau. Revue Therapeutique|February 3, 2006
[Leukopenia/neutropenia]M J Bargetzi
Schweizerische Medizinische Wochenschrift|March 23, 1991
[Bronchopulmonary sequestration]M J Bargetzi, J Saltzman, W Maurer
Journal of Immunological Methods|June 2, 1989
Diagnostic screening of multiple antigen-antibody reactions in a new single assay on nitrocellulose: the line immunobinding assay (LIBA)R E Aeppli, M J Bargetzi, H Binz
Helvetica Chirurgica Acta|December 1, 1987
[Duodenopancreatectomy: the results with 35 patients]R A Schori, M J Bargetzi, W Maurer
Schweizerische Medizinische Wochenschrift|November 9, 1996
[Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia]M J Bargetzi, A Tichelli, A Gratwohl, et al.
Biochemical and Biophysical Research Communications|November 13, 1987
MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylationR Fonne-Pfister, M J Bargetzi, U A Meyer
JAMA|February 10, 1989
Premenstrual exacerbations in hepatic porphyria: prevention by intermittent administration of an LH-RH agonist in combination with a gestagenM J Bargetzi, U A Meyer, M H Birkhaeuser
The American Journal of Medicine|October 1, 1990
Primary liver carcinoma in two sisters with acute intermittent porphyriaJ G Gubler, M J Bargetzi, U A Meyer
American Journal of Hematology|June 26, 2001
Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLLM Heizmann, P Itin, M Wernli, et al.
Pageof 3